"Just off of I-184, at the intersection of N Curtis Road and Emerald Street, Saint Alphonsus Boise Cancer Care Center offers care to the Boise community."

During the past decade, Saint Alphonsus Cancer Care Center-Boise conducted 202 clinical trials. In the 10-year time frame, 202 clinical trials started and 184 clinical trials were completed, i.e. on average, 91.1% percent of trials that started reached the finish line to date. In the past 5 years, 74 clinical trials started and 103 clinical trials were completed. i.e. 139.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Alphonsus Cancer Care Center-Boise" #1 sponsor was "National Cancer Institute (NCI)" with 159 trials, followed by "Alliance for Clinical Trials in Oncology" with 64 trials sponsored, "SWOG Cancer Research Network" with 61 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 25 trials sponsored and "Radiation Therapy Oncology Group" with 25 trials sponsored. Other sponsors include 42 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Alphonsus Cancer Care Center-Boise" #1 collaborator was "National Cancer Institute (NCI)" with 213 trials as a collaborator, "NRG Oncology" with 63 trials as a collaborator, "Canadian Cancer Trials Group" with 11 trials as a collaborator, "Cancer and Leukemia Group B" with 11 trials as a collaborator and "SWOG Cancer Research Network" with 10 trials as a collaborator. Other collaborators include 65 different institutions and companies that were collaborators in the rest 46 trials.

According to Clinical.Site data, the most researched conditions in "Saint Alphonsus Cancer Care Center-Boise" are "Breast Cancer" (21 trials), "Recurrent Ovarian Carcinoma" (15 trials), "Prostate Cancer" (12 trials), "Recurrent Fallopian Tube Carcinoma" (11 trials) and "Recurrent Primary Peritoneal Carcinoma" (11 trials). Many other conditions were trialed in "Saint Alphonsus Cancer Care Center-Boise" in a lesser frequency.

Most popular intervention types in "Saint Alphonsus Cancer Care Center-Boise" are "Drug" (293 trials), "Other" (215 trials), "Biological" (135 trials), "Procedure" (89 trials) and "Radiation" (80 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (108 trials), "Quality-of-Life Assessment" (77 trials), "Paclitaxel" (46 trials), "Questionnaire Administration" (44 trials) and "Carboplatin" (41 trials). Other intervention names were less common.

The vast majority of trials in "Saint Alphonsus Cancer Care Center-Boise" are 285 trials for "All" genders, 73 trials for "Female" genders and 18 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Alphonsus Cancer Care Center-Boise". undefined are not yet recruiting, 75 are recruiting, 152 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 118 completed trials in Saint Alphonsus Cancer Care Center-Boise, 8 suspended trials, and 19 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Alphonsus Cancer Care Center-Boise, 17 "Phase 1" clinical trials were conducted, 189 "Phase 2" clinical trials and 180 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 9 trials that are defined as “Not Applicable".